Back to search results

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1

Conditions

Ovarian Cancer · Pancreas Cancer · Urothelial Carcinoma · Renal Cell Carcinoma · Hepatocellular Carcinoma · Gastrointestinal Cancer · Lung Cancer · Prostate Cancer · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Southern California, Los Angeles, California, United States

    Contact: Study coordinator (Anthony El-Khoueiry, MD) · elkhouei@med.usc.edu · 323-865-3962

  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles, California, United States

    Contact: Study coordinator (Kamya Sankar, MD) · kamya.sankar@cshs.org · 248-802-2041

  • Cedars-Sanai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Alain Mita, MD)

  • Hoag Memorial Hospital Presbyterian, Newport, California, United States

    Contact: Study coordinator (Benjamin Goldenson, MD) · Benjamin.Goldenson@Hoag.org · 949-764-4060

  • Sarah Cannon Research Institute - Denver DDU, Denver, Colorado, United States

    Contact: Study coordinator (Jason T Henry, MD) · Jason.Henry2@SarahCannon.com · 720-754-2610

  • Emory University - Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Fatemeh Ardeshir, MD) · fatemeh.ardeshir.larijani@emory.edu · 404-778-0202

  • New York Cancer & Blood Specialists, New York, New York, United States

    Contact: Study coordinator (Richard Zuniga, MD) · zunigaresearch@nycancer.com · 613-675-5075

  • University of Rochester - Wilmot Cancer Institute, Rochester, New York, United States

    Contact: Study coordinator (Brea Lipe, MD) · brea_lipe@urmc.rochester.edu · 585-276-6302

  • START San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Drew Drasco, MD) · drasco@startsa.com · 210-593-5258

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Binod Dhakal, MD)
Study leads

  • Dennis Kim, MD

    Study Director

    Nammi Therapeutics Inc

View source on ClinicalTrials.gov(opens in a new tab)